FDAnews
www.fdanews.com/articles/200988-medibio-gains-ce-mark-for-sleep-stage-analysis-software

Medibio Gains CE Mark for Sleep-Stage Analysis Software

January 22, 2021

Medibio has received CE mark certification for its artificial intelligence (AI)-powered sleep- stage analysis software, MEBsleep.

The software-only medical device analyzes electroencephalogram (EEG) and electrocardiogram (ECG) data collected during sleep studies to verify sleep stages and heart-rate variability in patients with primary or secondary sleep disturbances.

MEBsleep uses machine learning based on neural-network technology to assess large amounts of raw data on a patient’s body functions during sleep to help physicians assess the patient’s condition.

View today's stories